Stock 1177 SINO BIOPHARMACEUTICAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Sino Biopharmaceutical Limited

Equities

1177

KYG8167W1380

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:16 2024-04-24 am EDT 		5-day change 1st Jan Change
2.68 HKD +3.88% Intraday chart for Sino Biopharmaceutical Limited +5.51% -22.77%
Apr. 22 Lull in Geopolitical Tensions Lifts Asian Stock Markets MT
Apr. 22 Hong Kong shares jump on policy support; China slips RE

Evolution of the average Target Price on Sino Biopharmaceutical Limited

Price target over the last 5 years

History of analyst recommendation changes

c9d5a69cbb1bab565c6.Eqcrnwhn9d76N9LFEsFkfVxqel98YL5FCaDtyuGhuFU.d-xK6m0BmbW2WbGBVIgUTRE1T24kCPswZvCYqJbn5zgh3xjKMRCmt6lemw~afc5ee19e5ebacd284d4297de329ccea

Analyst Recommendations on Sino Biopharmaceutical Limited

Nomura Adjusts Sino Biopharmaceutical’s Price Target to HK$6.16 From HK$6.63, Keeps at Buy MT
Sino Biopharmaceutical Gets 'A' ESG Rating from MSCI MT
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$6.63 From HK$7.43, Keeps at Buy MT
Nomura Adjusts Sinobiopharma's Price Target to HK$7.43 From HK$7.78, Keeps at Buy MT
UBS Adjusts Sino Biopharmaceutical's Price Target to HK$7.5 From HK$8, Keeps at Buy MT
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$7.78 From HK$8.19, Keeps at Buy MT
Nomura Adjust Sino Biopharma’s Price Target to HK$8.19 From HK$8.53, Keeps at Buy MT
UBS Adjusts Sino Biopharmaceutical's Price Target to HK$8 From HK$11.6, Keeps at Buy MT
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$8.53 From HK$9.38, Keeps at Buy MT
SINO BIOPHARMACEUTICAL : Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$9.3 From HK$8.97, Keeps at Buy MT
Market Chatter: Hong Kong's Vaccination Rate Plunges Amid Fears of COVID-19 Jab Complications MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
2.479 CNY
Average target price
4.32 CNY
Spread / Average Target
+74.25%
High Price Target
8.46 CNY
Spread / Highest target
+241.22%
Low Price Target
2.806 CNY
Spread / Lowest Target
+13.18%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Sino Biopharmaceutical Limited

Nomura
UBS

Ratings for Sino Biopharmaceutical Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 1177 Stock
  4. Consensus Sino Biopharmaceutical Limited